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Summary (250 words) and Main text (3986 words)  
 
Essentials 
 Dimeric high-affinity collagen receptor glycoprotein VI (GPVI) is present on resting 
platelets. 
 Spatio-temporal organization of platelet GPVI-dimers was evaluated using advanced 
microscopy. 
 Upon platelet adhesion to collagenous substrates, GPVI-dimers coalesce to form 
clusters. 
 Clustering of GPVI-dimers may increase avidity and facilitate platelet activation 
 
Summary 
Background:  Platelet GPVI binding to subendothelial collagen exposed upon blood vessel 
injury initiates thrombus formation. Dimeric GPVI has  high affinity for collagen and occurs 
constitutively on resting platelets. Objective: To identify higher order oligomerisation 
(clustering) of pre-existing GPVI-dimers upon interaction with collagen as a mechanism to 
initiate  GPVI-mediated signalling. Methods:  GPVI was located using fluorophore-
conjugated GPVI-dimer-specific Fab (antigen-binding fragment).  Tested substrates include 
Horm collagen I fibres, soluble collagen III, GPVI-specific collagen peptides and fibrinogen. 
GPVI-dimer clusters on the platelet surface interacting with these substrates were visualised 
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using complementary imaging techniques: Total Internal Reflection Fluorescence 
Microscopy (TIRFM) to monitor real time interactions and direct Stochastic Optical 
Reconstruction Microscopy (dSTORM), providing relative quantification of GPVI cluster size 
and density. Confocal microscopy was used to locate GPVI-dimer clusters, GPIb, integrin 
α2β1, and phosphotyrosine. Results: Upon platelet adhesion to all collagenous substrates, 
GPVI-dimers coalesced to form clusters; notably clusters formed along the fibres of Horm 
collagen.  dSTORM revealed that GPVI density within clusters depended on the substrate, 
collagen III being most effective. Clusters on fibrinogen-adherred platelets were much 
smaller and more numerous; whether these are pre-existing oligomers of GPVI-dimers or 
fibrinogen-induced is not conclusive.  Some GPVI-dimer clusters colocalized with areas of 
phosphotyrosine, indicative of signalling activity. Integrin α2β1 localized to collagen fibres 
close to GPVI-dimer clusters.  GPVI-clustering depends on a dynamic actin cytoskeleton.  
Conclusions: Platelet adhesion to collagen induces GPVI-dimer clustering. GPVI-clustering 
increases both avidity for collagen and proximity of GPVI-associated signalling molecules, 
which may be crucial for initiation and persistence of signalling. 
 
Introduction 
Upon blood vessel injury, circulating platelets interact with exposed subendothelial collagen 
through the collagen receptor glycoprotein VI (GPVI).  This 65-kDa immune receptor signals 
through its associated Fc-receptor γ-chain, which contains an immunoreceptor tyrosine-
based activation motif (ITAM) in its intracellular domain.  Binding of GPVI to collagen 
induces phosphorylation of the ITAM residues, which can then bind to Syk, itself becoming 
phosphorylated and activated. This process initiates signalosome assembly [1], leading to a 
series of downstream signals, resulting in platelet activation, finally culminating in thrombus 
formation. 
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   GPVI contains two extracellular Ig-like domains: D1 containing the collagen binding site 
[2,3] and D2, connected via an O-glycosylated stem to its transmembrane domain and short 
cytoplasmic tail [4].  GPVI binds to tandem GPO (glycine-proline-hydroxyproline) sequences 
in collagen [5,6].  Surface plasmon resonance showed that dimerized recombinant GPVI 
(D1D2-Fc)2 bound collagen fibres with high affinity but binding of its monomeric form (D1D2) 
was too low to measure [7].  Monomeric and dimeric recombinant D1D2 showed similar 
affinity for collagen-related peptide (CRP), a triple-helical peptide containing 10 contiguous 
GPO triplets, suggesting GPVI-dimer may have a specific conformation that recognizes the 
higher-order structure of fibrous collagen, beyond simply the GPO sequences. The crystal 
structure of a D1D2 dimeric assembly [8] allowed docking simulations [3,5,8] which 
suggested that D1 contained grooves large enough to accommodate the triple-helical CRP.  
In 2009, Jung et al. provided direct evidence for the presence of dimers on the resting 
platelet surface with GPVI-dimer specific, inhibitory m-Fab-F [9]. Later, they reported a non-
inhibitory Fab, 204-11, which recognized GPVI-dimers [10], and used it to show that GPVI-
dimers were constitutively present on resting platelets. These observations suggested that 
the first interaction in collagen-induced activation of platelets is collagen binding to GPVI-
dimers. Several groups, however, reported that platelet activation induced formation of 
GPVI-dimers. Arthur et al. (11) provided biochemical evidence for disulphide-linked dimers in 
activated platelets. Loyau et al., employing GPVI-dimer–specific mab 9E18, reported that 
GPVI dimerization was induced by soluble agonists or VWF, with almost no dimersdetected 
on resting platelets [12], leading them to propose dimer formation as a means to control 
collagen-induced platelet activation.  Dimerization is an accepted mechanism for cell 
activation through receptor tyrosine kinases [13], where ligand binding to the receptor 
extracellular domains induces dimerization, causing a conformational change that brings 
together the kinase domains in the cytoplasmic tails, facilitating autophosphorylation, thereby 
initiating intracellular signals.  The Src-family kinase Lyn associates with the cytoplasmic tail 
of GPVI [14], which lacks intrinsic kinase activity, so that FcRγ attached to one GPVI 
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monomer might be phosphorylated by Lyn associated with a second monomer, brought into 
proximity by dimerization. 
 An alternative activation mechanism would be higher-order receptor clustering [15], which 
does not preclude the presence of constitutive GPVI-dimers in non-activated platelets.  
Clustering has been demonstrated for many classes of receptor, including G protein–
coupled receptors [16]; adhesion receptors such as platelet integrin αIIbβ3 [17]; platelet 
CLEC-2 [18] and notably, the discoidin domain receptor, DDR1, a constitutively-dimeric 
tyrosine kinase receptor for collagen [19].  
As GPVI dimers are present on resting platelets we hypothesize that a further level of control 
is required.  We hypothesize that clustering of GPVI-dimers is a plausible mechanism to 
modulate platelet activation once the high-affinity, but low-copy-number, GPVI-dimers 
engage the limited number of binding sites on collagen [2,20].  The formation of GPVI 
clusters could result in increased avidity and may bring associated signalling molecules 
together to facilitate platelet activation.  We used complementary imaging techniques to test 
this hypothesis:  TIRFM (Total Internal Reflection Fluorescence Microscopy), to visualize in 
real-time GPVI-dimer distribution at the interface between the platelet membrane and 
immobilized collagenous substrates; dSTORM (Direct Stochastic Optical Reconstruction 
Microscopy) for relative quantification of GPVI cluster size and density; and confocal 
microscopy to compare localization of GPVI-dimers and two other receptors involved in the 
platelet-collagen interaction, GPIb and integrin α2β1, and whether signalling was associated 
with the clustered GPVI-dimers.  
 
Materials and methods  
Non-inhibitory, recombinant dimer-specific 204-11 Fab [10] was derived from clone 204-11 
[21] by Kaketsuken (Kumamoto, Japan).  Antibodies were fluorescently labelled by a 
Microscale Protein Labelling kit (Molecular Probes); degree of fluorescent labelling =2–5 dye 
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molecules/protein molecule. 4G10 (anti-phosphotyrosine; Millipore Merck); Anti-human 
CD42b/GPIb, clone 486805 (R&D Systems); 16B4 (mouse anti-human CD49b/integrin α2 
chain; AbD Serotec); Alexafluor 647–conjugated AffiniPure F(ab’)2 fragment goat anti-
mouse IgG, Fcγ–specific (Jackson); Gi9 (anti-integrin α2; Abcam), Alexafluor 647–anti-
human CD62P (Bio-Rad).  Other materials, reagent grade or better, were obtained from 
commercial sources. 
 
Platelet preparation 
Washed platelets were prepared from ACD-anti-coagulated blood from healthy volunteers 
(22) and resuspended at 3–5 x 107 platelets/ml in Hepes-Tyrodes buffer (HT: 134 mM NaCl, 
0.34 mM Na2HPO4, 2.9 mM KCl, 12 mM NaHCO3, 20 mM HEPES, 5 mM glucose, pH 7.3). 
Preparation of collagenous substrate–coated glass dishes for imaging 
35-mm glass (0.7 mm)–bottomed MatTek dishes (MatTek, USA) were coated with 10 µg/ml 
CRP-XL, III-30, or collagen III, in phosphate-buffered saline (PBS: 0.01 M phosphate buffer, 
0.0027 M KCl, 0.137 M NaCl,pH 7.4 ); Horm collagen, in manufacturer-supplied diluent) 
overnight at 4C.  The dishes were PBS-washed, 1% bovine serum albumin–blocked 
(BSA/PBS; heat-denatured,filtered) for 1 h, and then PBS-washed ready for platelet 
spreading. 
 
TIRFM 
Adhesion of Alexafluor 488–204-11 Fab–labelled washed platelets (3 x 107 platelets/ml in 
HT buffer containing 2 mM MgCl2) to immobilized collagenous substrate was imaged by 
TIRFM (Nikon TIRF system mounted on a Nikon Eclipse Ti inverted microscope, with Nikon 
60x NA 1.49 TIRF objective).  Images were obtained at 5-s intervals for 20–30 min at 37oC, 
followed by fixation in formalin and confocal imaging.  Integrin α2β1–blockade was achieved 
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by preincubating platelets with 10 μg/ml Gi9 blocking antibody.  Platelet morphology was 
followed using differential interference contrast (DIC) microscopy      
 dSTORM   
Alexafluor 647-204-11 Fab–labelled washed platelets were allowed to adhere to 
collagenous-substrate-coated MatTek dishes.  Adhered platelets were fixed, permeabilised 
and stained with Phalloidin-Alexa488.  Samples were imaged in switching buffer as 
described previously (22) on a Nikon Eclipse Ti-E N-STORM system in dSTORM mode 
using Perfect Focus, with a CFl SR Apochromat TIRF 100x Oil, 1.49NA objective lens and 
an N-STORM filter cube with excitation using the Agilent Ultra High Power Dual Output 
Laser bed (170-mW 647-nm laser), and image capture with an Andor IXON Ultra 897 
EMCCD camera.  30,000 frames were captured using Nikon NIS Elements v4.2 and 
reconstructed using STORM analysis module v3.2 with drift correction and Gaussian 
rendering of data points. Detected points with a photon count of less than 500 were 
discarded from reconstructed data before further processing. Points in the reconstructed 
images represent individually identified fluorescent blinking events, which are referred to as 
molecules. 
Confocal imaging 
Platelets were preincubated with Alexa 488 or 647–conjugated 204-11 Fab (4 μg/ml) alone 
or with another fluorescently labelled antibody. In some experiments, platelets were also 
treated with an inhibitor or inhibitory antibody. The platelets were allowed to adhere to a 
collagenous substrate, fixed and imaged with an FV300 IX81 Laser-scanning confocal 
microscope, 60x oil immersion objective (Olympus). Where indicated, platelets were 
permeabilized (0.1% Triton/PBS) following fixation and stained for actin (Alexafluor 647–
Phalloidin) or phosphotyrosine (4G10,5 μg/ml). 
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Flow cytometry to measure GPVI-dimers 
Washed platelets were pre-incubated with DMSO (0.25% final concentration) or actin 
antagonist (cytochalasin D, latrunculin A, or jasplakinolide; 10 µM; 0.25% DMSO, final 
concentration), and GPVI-dimer formation was measured by flow cytometry [10]. 
 
Data analyses 
Data analyses,performed with Prism v7 (GraphPad, San Diego, CA), are described in the 
figure legends.  Differences among treatment groups in the flow cytometry experiments were 
calculated by paired t-test. dSTORM cluster analysis was performed within MATLAB for 
each 3 x 3 µm ROI (region of interest) as described by Owen et al. [23] with modifications 
described in Pollitt et al. [18].  Platelets were identified by phalloidin staining of the actin 
cytoskeleton.  ROIs were positioned within the platelet ensuring that the edges of the ROI 
fell within the platelet boundary.  Clusters of <3 points were discounted. The numerical data, 
processed using Microsoft Excel, were analysed as detailed in the figure legends. The 
degree of colocalization between the GPVI and phophotyrosine confocal images was 
quantified by Image-Pro Premiere 9.2 (Molecular Cybernetics). 
 
Results 
TIRFM imaging of GPVI-dimer–cluster formation in live platelets interacting with immobilized 
collagenous substrates 
We investigated the spatial and temporal distribution of GPVI dimers on the surface of 
platelets interacting with different immobilized collagenous substrates (Table I).  Washed 
platelets labelled for GPVI-dimer were allowed to adhere, and cluster formation and 
dynamics were visualized by TIRFM (Fig.1; supplemental movie).  Discrete clustered GPVI-
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dimers can be visualized in spreading platelets, whereas non-clustered GPVI-dimers are 
poorly-resolved, appearing as diffuse fluorescence over the platelet surface. 
   GPVI dimers form clusters on platelets adhering to all collagenous substrates tested.  
Cluster formation on fibrous Horm collagen (Horm) follows a distinct distribution, 
concentrated along the collagen fibre (Fig. 1A: i, ii), initially forming at the point of contact 
between the platelet and the fibre, then propagating along the fibre (Fig. 1Aii). Clusters are 
not restricted to the visible collagen fibre and are also present on the platelet surface 
presumably due to indirect signal-induced clustering (e.g., outside-in signalling through 
released substances such as fibrinogen, ADP, VWF, etc.), through contact with smaller 
(non-visible) fibres in these portions of the surface, or both.  Non-fibrous collagenous 
substrates CRP-XL (Fig. 1B), collagen III (Fig. 1C, Col III), and III-30 (Fig. 1D, III-30) also 
support formation of GPVI-dimer clusters, each with similar cluster distributions.  Small 
clusters were evident upon first contact of the platelet with the coated surface, eventually 
forming throughout the platelet surface; some clusters expanded and coalesced.  
 
Different collagenous substrates induce different degrees of clustering 
GPVI-clustering in fixed platelets spread on the different collagenous substrates was 
quantitated using dSTORM, which has a typical x-y resolution of 20–30 nm (24, 25). 
Widefield TIRF imaging of the platelets labelled for F-actin and GPVI dimer show the same 
distribution of GPVI as that observed in the live-cell imaging (Fig. 2A). Cluster analysis of 
dSTORM data is represented by the heat maps in Fig.2A. High and low levels of GPVI-
clustering are seen as red and blue, respectively. All collagenous substrates induced more 
GPVI-clustering than expected to occur randomly; however, the cluster distribution 
depended upon the specific substrate. Horm induced high degrees of clustering along the 
fibres, whereas the other substrates induced clusters more evenly distributed throughout the 
ROI. Quantification shows that there are more GPVI dimers and a greater number of clusters 
found per unit area on platelets spread on Col III than on the other substrates (Fig. 
2B,C).These clusters are small (Fig. 2D) but contain the highest density of GPVI dimers (Fig. 
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2E, median values).  Horm induced the next highest amount of GPVI dimer per ROI, 42% 
less than Col III, and Horm-induced clusters were 31% less dense than those on Col III. 
CRP-XL and III-30 were least effective in dimer formation (each with ~70% fewer molecules 
detected in the ROI compared to Col III) and cluster densities were also correspondingly 
reduced when compared to Col III (40% and 37% reduction, respectively).   The size of 
GPVI-dimer clusters formed on Horm and CRP are not significantly different from each other 
but were significantly larger than those formed on Col III and III-30 (Fig. 2D).   In summary, 
all collagenous substrates cause GPVI dimers to cluster, but different numbers of dimers 
and densities of GPVI within clusters are formed, depending on the nature of the 
collagenous substrate.   
GPVI dimers are not restricted to the platelet membrane in direct contact with the visible 
collagen fibres (Figs. 1A, 2A).  Potential explanations for this are the existence of “non 
visible” microfibers in those areas, to which GPVI-dimers can still bind, and/or fibrinogen or 
other substances released from adhered platelets may induce cluster formation via outside-
in signalling. To determine whether GPVI clusters can form by collagen-independent platelet 
activation, platelets were spread on fibrinogen and clustering of GPVI dimer quantified using 
dSTORM (Fig 3).  GPVI-dimer clusters seen on fibrinogen differ from those seen on Horm 
collagen: relative density of dimers in platelets spread on fibrinogen is ~50% less when 
compared to platelets spread on Horm (Fig 3B); there are many more small clusters on the 
fibrinogen, and the small clusters are ~40% less dense than those formed on Horm (3C–E). 
Although it is possible that GPVI-dimer clustering can occur by a GPVI-independent 
mechanism, collagen greatly increases the formation of GPVI dimers, which coalesce into 
larger and denser clusters.  
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Relationship between clustered GPVI-dimers and other receptors involved in the platelet–
collagen interaction 
Localisations of other receptors involved in the platelet-collagen interaction, GPIb (Fig. 4A) 
and integrin 2β1 (Fig. 4B), were compared to that of GPVI-dimer clusters on platelets 
adhered to collagenous substrates.  GPVI-dimer clusters form along Horm collagen fibres, 
whereas they appeared throughout the lamellipodia of platelets spread on Col III and III-30.  
Like GPVI-dimer clusters, α2β1 was also found to localize along Horm collagen fibres, but 
was confined to the cell body of platelets adhered to Col III and III-30; no co-localisation with 
GPVI-dimer clusters was observed on the platelet lamellipodia. GPIb (VWF receptor) did not 
associate with GPVI-dimer clusters in the lamellipodia of any of the collagenous substrates 
tested, remaining in the platelet cell body. 
 
Contribution of collagen receptor integrin α2β1 to platelet adhesion and GPVI-dimer cluster 
formation 
Platelets labelled with Alexafluor 488–204-11 Fab with or without Gi9 (α2β1-blocking 
antibody), were allowed to settle onto immobilized non-fibrous collagen III or Horm fibres, 
and monitored by TIRFM. Gi9 treatment prevented platelet adhesion to collagen III, but 
merely decreased the extent of GPVI-dimer cluster formation on Horm fibres (Fig. 4C). Gi9 
had no effect on platelet adhesion/cluster formation on the GPVI-specific ligands CRP-XL 
and III-30 (data not shown). 
Effect of Src-family and Syk kinase inhibition on GPVI cluster formation  
Confocal images of platelets adhered to Horm, Col III, III-30, or CRP-XL show that areas rich 
in phosphotyrosine co-localize with some of the GPVI-dimer clusters (Fig. 5A), suggesting 
signalling is occurring in these regions.  Degree of colocalization was analysed using 
Pearson’s correlation (Fig. 5B, right).  To investigate whether protein tyrosine 
phosphorylation is important in GPVI cluster formation, platelets were treated with the Syk 
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inhibitor PRT-060318 or Src-family kinase inhibitor PP2.  Both inhibitors, at concentrations 
demonstrated to inhibit spreading and phosphorylation in human platelets [26], inhibited 
adhesion on Horm and Col III. Both inhibitors reduced platelet spreading on all collagenous 
substrates (Supplementary Fig. 1 shows corresponding DIC images that enable visualisation 
of platelet morphology in the presence and absence of the inhibitors). Despite having a 
reduction in spreading, discrete GPVI-dimer clusters were visible in platelets adhered to 
CRP XL and III-30 in the presence of PRT-060318 or PP2 (Fig. 6). 
 
Effect of disrupting actin dynamics on GPVI-dimerisation and clustering 
Flow cytometry was used to quantify effects of drugs that inhibit actin dynamics on GPVI-
clustering:  Cytochalasin D (cyt) and Latrunculin A (lat), actin polymerization–blockers, and 
Jasplakinolide (jas), F-actin stabilizer.  All three inhibitors (10 μM) significantly decreased 
GPVI-dimer levels in resting platelets (Fig. 7A,B).  To avoid total abolition of adhesion, we 
used low-dose (2 μM)  actin antagonist to assess the role of the actin cytoskeleton in 
clustering of GPVI-dimers on Horm, Col III, CRP-XL, and III-30 (Figs. 7C–D,respectively). 
Low-dose Latrunculin A disrupted the actin cytoskeleton and severely depressed cluster 
formation, with platelets that did adhere not spreading. Low-dose Jasplakinolide had similar 
but more severe effects on cluster formation, with no apparent F-actin staining, and fewer 
adhered, but non-spread platelets.    
 
Discussion 
GPVI-dimers constitutively present on resting platelets are the collagen-binding form of this 
receptor, having over 100-fold higher affinity for collagen than the monomer [9,10].  The 
constitutive presence of dimers suggests that a mechanism beyond the formation of dimers 
may be necessary to initiate signalling through GPVI.  One mechanism may be the formation 
of higher-order oligomers (clusters) which has been demonstrated to play an important role 
in the amplification, maintenance and termination of receptor signalling in many cell types 
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[27,28], including platelets [18,27]. We propose that GPVI clusters which may recruit 
signalling molecules to facilitate platelet activation. To explore this hypothesis, we used 
complementary imaging methods: TIRFM, dSTORM, and confocal microscopy.   
     TIRFM enabled the temporal visualisation of GPVI-cluster formation at the surface of 
platelets spreading on collagenous substrates.  After the initial contact of GPVI-dimer with 
the substrate, the number of GPVI-dimer clusters increases rapidly.  Notably, in platelets 
adhered to fibrous Horm collagen, discrete clusters form along the fibres first, then 
throughout the surface of the spread platelet (Fig.1A). This is consistent with GPVI-dimers 
interacting with the surface of the collagen fibre, forming clusters at those points, followed by 
signalling that induces more cluster formation in regions of the platelet not in direct contact 
with the visible fibre.  A different clustering pattern is observed on the immobilized non-
fibrous collagenous substrates, CRP-XL (Fig. 1B) and III-30 (Fig. 1D), which exclusively bind 
GPVI, and soluble Col III (Fig. 1C), which binds GPVI and α2β1. Immobilized non-fibrous 
substrates are randomly-orientated triple-helical molecules and would be expected to 
support a different clustering pattern than Horm collagen fibers, which contain a highly 
organised parallel assembly of triple-helical tropocollagen molecules within the microfibrils.  
This structure dictates that GPVI-binding sites will be distributed on the surface of a fibre at 
fixed lateral and axial intervals, and suggests that a GPVI-dimer would be able interact with 
neighbouring tropocollagen molecules presenting either separate or a composite binding 
sites [20].  
     dSTORM allows single fluorophore molecules to be detected and located with very high 
spatial precision. Combined with cluster analysis, dSTORM allows quantitation of the 
number of GPVI dimer molecules and cluster number, size and density in ROIs within a 
spread platelet. This information permits the relative differences in GPVI clusters to be 
compared in platelets spread on different substrates.  Horm collagen fibres induced a high 
degree of clustering by virtue of their structure, outlined above. The spacing and orientation 
of the two proposed collagen-binding grooves of GPVI-dimer might allow it to bind with 
increased avidity to sites on adjacent tropocollagen molecules, allowing clustering to occur 
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[20].  The ability of immobilized III-30, CRP-XL, and Col III to bind GPVI will depend on the 
density and relative orientation of the immobilized substrate helices.  CRP and III-30 contain 
only GPVI-binding motifs, the former having more GPVI-reactive GPO triplets per molecule, 
whereas immobilized soluble Col III binds both GPVI and α2β1, which may support 
cooperative platelet binding, since motifs for each receptor are located close together. Such 
differences may explain the variation in cluster density observed between the different 
collagenous substrates. Indeed, both Horm and Col III had significantly higher GPVI cluster 
density than III-30, and Col III clusters were also significantly denser than those on CRP-XL, 
suggesting a measurable role for 21 in these events.    
     On platelets adhered to non-fibrous Col III and III-30, GPIb (Fig. 4A) and 21 (Fig. 4B) 
do not co-localize with the majority of the GPVI-dimer clusters, which are located in the  
lamellipodia of the spread platelet.  However, α2β1 is indispensable for platelet binding to 
soluble Col III, since adhesion is severely reduced by the blocking anti-integrin α2β1 
antibody Gi9. Synergism between GPVI and α2β1 has also been observed using 
immobilized model peptides in flowing blood thrombus deposition studies [31].  In contrast, 
Gi9 did not prevent platelet adhesion/cluster formation on fibrous Horm collagen, indicating 
that GPVI binding to the collagen fibre is much stronger than to non-fibrous substrates. 
These observations are consistent with GPVI being sufficient to support platelet binding to 
collagen fibres but not to soluble collagen [32].  Integrin 21 was also located along Horm 
collagen fibres in bound platelets, and the magnified confocal images (Fig. 4B) suggest that 
α2β1 binds close to some of the GPVI-dimer–clusters on the fibre. The model proposed by 
Herr and Farndale [20] suggests that α2β1 and GPVI might bind ~10nm apart in collagen III, 
and inspection of the collagen I sequence suggests that similar considerations would apply 
to Horm collagen. Although non-activated α2β1 may bind its high affinity motif, GFOGER, in 
Horm fibres [33], this is not essential for GPVI-dimer binding and clustering.  However, 21 
may serve to accelerate platelet adhesion to the collagen fibre [34], thus facilitating further 
GPVI-clustering.  Under the present static adhesion conditions, however, the distribution of 
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GPIb differed from that of the GPVI dimer–clusters on collagen fibres, although GPIb was 
observed in the platelet cell body, adjacent to the fibre (Fig. 4A).  A Mab against GPIb (SZ2) 
was reported to block CRP-XL–induced platelet aggregation, and GPIb to co-precipitate with 
GPVI in both resting and thrombin-stimulated platelets, suggesting an interaction between 
the two receptors [35].  Platelet adhesion to collagen under high shear requires VWF 
multimers, via GPIb, to tether the platelet to collagen, but our experiments are performed 
under static conditions in the absence of plasma VWF, so GPIb is less important. 
     What induces GPVI clustering?  One possibility is that platelet activation induced by the 
initial interaction of GPVI with collagen leads to GPVI oligomerisation.  However, in spite of 
severe inhibition of platelet spreading by the Syk inhibitor PRT-060318, limited cluster 
formation on all four immobilized collagenous substrates was still observed (Fig. 6, right).  
The marked inhibition of cluster formation on Col III (which lacks the high-affinity motif, 
GFOGER) would be due to blocking α2β1 activation, hence removing the contribution of its 
high affinity form to stabilize platelet binding to collagen.  Src-family kinase inhibitor PP2 also 
inhibited platelet adhesion, but to a lesser extent than PRT-060318 (Fig. 6, middle).  
Alternatively, blockade of both Src and Syk might potently inhibit secretion [36,37], 
preventing release of active substances (including fibrinogen), thus reducing clustering via 
secondary signaling pathways.  These results suggest that, whilst platelet adhesion and 
spreading is fully dependent on GPVI-mediated signalling, GPVI-cluster formation is only 
partly so. 
   Movement of membrane proteins is controlled, in part, by the cytoskeleton in other cells 
[38].  Inhibitors of actin dynamics at 10 μM inhibited GPVI-dimer formation in resting platelets 
and prevented the GPVI-dimer increase in CRP-XL– or thrombin-activated platelets (Fig. 
7A,B).  At 2 μM, a threshold inhibitory concentration, there is severely limited adhesion of 
non-spread platelets on all 4 tested substrates, but there is evidence of residual cluster 
formation and disturbed actin filament distribution. These results suggest the contribution of 
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the peripheral membrane cytoskeleton to GPVI cluster formation, a topic for future 
investigation.   
     Although the GPVI-dimers on resting platelets are competent to bind collagen, they are 
not exposed to it in an uninjured vessel and the low density of GPVI-dimers in resting 
platelets (1500/platelet) [10] suggests that they may be too far apart to induce efficient 
signalling; thus platelets remain inactive, the GPVI-dimers requiring both receptor ligation 
and proximity to activate platelets. However, upon vessel injury, subendothelial collagen 
fibres are exposed to the bloodstream, and efficient platelet activation is necessary to 
prevent bleeding.  Once a vessel is injured, the binding sites on fibres of collagen types I and 
III become accessible to the receptors involved in the platelet–collagen interaction GPVI, 
integrin α2β1, and GPIb.  The proximity of GPVI-dimer binding sites on the fibre surface 
enable clustering of GPVI-dimers, increasing avidity and bring together necessary signalling 
components to initiate signalling and lead to efficient platelet activation and thrombus 
formation.  We examined GPVI-dependent signalling in the vicinity of GPVI clusters, and 
whether inhibitors of GPVI-mediated signalling affected clustering.  The proximity of 
phosphotyrosine to some of the GPVI clusters (Fig. 5), particularly on the Horm fibres, 
suggests local tyrosine kinase activity.  Jamasbi et al. (39) recently reported that GPVI-Fc 
(Revacept) bound to collagen fibres can be clustered by the addition of anti-Fc, consistent 
with dimers binding in close enough proximity in the collagen fiber to allow cluster formation. 
Activation induces formation of more dimers, as evidenced by the increased dimer numbers 
in CRP-XL- or thrombin-activated platelets [10], enabling formation of even more clusters.  
Moreover, activation of platelets leads to activation of 21, increasing its affinity for 
collagen, causing firm adhesion. Our present study suggests that platelets have two layers 
of activity regulation through GPVI—conversion of monomers to high affinity dimers, and 
clustering of the GPVI-dimers.  Clustering would serve to increase both avidity for collagen 
and signalling molecule recruitment, leading to efficient platelet activation during thrombus 
formation.   
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Figure Legends 
Fig. 1.  GPVI forms clusters when platelets spread on immobilized collagenous substrates.   
TIRF microscopy time course of washed human platelets, labelled with Alexafluor-488–
conjugated, dimer-specific 204-11 Fab, interacting with 10 µg/ml immobilized collagenous 
substrates at 37°C. (A (i)) Horm collagen, (B) CRP-XL, (C) non-fibrous collagen type III and 
(D) peptide III-30.  The position of Horm collagen fibres are indicated on a DIC image by the 
dashed lines (A (ii)).   Images are a single platelet representative of three independent 
experiments.  See Supplemental Movie 1.  Time stamp: seconds. Scale bar: 2µm. 
Figure 2: dSTORM analysis of GPVI clustering on collagenous substrates 
A) Platelets spread on the collagenous substrates indicated were labelled for dimeric GPVI 
using the Alexa-647 conjugated Fab 204-11 (magenta) and F-actin using Alexa-488-
Phalloidin (green) and imaged by TIRF (top row). The GPVI was also imaged by dSTORM 
with the localised points (molecules) shown in the second row. The cluster heat map of the 
GPVI dSTORM  data in the 3µm x 3µm region of interest (ROI; dashed box in images)  is 
shown in the third row where red indicates high degrees of clustering. The threshold value of 
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a cluster was set to L(r)=100. Quantitative analysis of GPVI dSTORM clustering shows the 
number of molecules detected in the 3µm x 3µm ROI (B), the number of clusters in the ROI 
(C), the size of the clusters (in nm2; (D)) and the density of the molecules within the clusters 
(E). All graphs have the median and interquartile range indicated in red. Statistical analysis: 
Non-parametric Kruskal-Wallis ANOVA  with Dunn’s multiple comparison. Green lines 
indicate significance of P<0.001, Blue is P<0.01, Orange P<0.05, no line indicates no 
significance. Scale bar: 5 µm. A total number of n≥70 ROIs taken from 3 or 4 independent 
experiments were analysed for each collagenous substrate. 
 
Fig. 3: Comparison of GPVI clustering on Horm collagen and fibrinogen 
A) Platelets spread on the Horm or fibrinogen as indicated on top were labelled for dimeric 
GPVI using the Alexa-647 conjugated Fab 204-11 (magenta) and F-actin using Alexa-488-
Phalloidin (green) and imaged by TIRF. The GPVI was also imaged by dSTORM with the 
localised points (molecules) shown in the second row. The cluster heat map of the GPVI 
dSTORM  data in the 3µmx3µm region of interest (ROI; dashed box in images)  is shown in 
the third row where red indicates high degrees of clustering. The threshold value of a cluster 
was set to L(r)=100. Quantitative analysis of GPVI dSTORM clustering shows the number of 
molecules detected in the 3µm x 3µm ROI (B), the number of clusters in the ROI (C), the 
size of the clusters (in nm2; (D)) and the density of the molecules within the clusters (E). All 
graphs have the median and interquartile range indicated in red. Statistical analysis: If data 
passed a normality test then a t-test was performed (For ‘number of clusters’). If data was 
not normally distributed a non-parametric Mann-Whitney test was used. *** is where P< 
0.001. Scale bar: 5 µm. A total number of n≥90 ROIs taken from 3 independent experiments 
were analysed for each substrate. 
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Fig. 4. Comparison of distributions of GPVI-dimer clusters, GPIb, and integrin α2β1 on 
adhered platelets and the effect of inhibiting integrin α2β1 on cluster formation and 
adhesion. 
A. (GPIb) and B (integrin α2β1): Confocal images of adhered platelets prelabelled with 
Alexa-fluor 488–204-11 Fab (anti-GPVI-dimer; 4 μg/ml, green) and Alexafluor 647–anti-
human CD42 clone 486805 (anti-GPIb, 5 μg/ml, red) or Alexafluor 647–16B4 (anti-integrin 
α2β1; 5 μg/ml, red) and then allowed to adhere on Col III, III-30, or Horm coated dishes. 
Transmitted light images are included to show degree of spreading and magnified images of 
the platelet(s) indicated by white arrows are included.  Distributions of GPIb are different 
from those of the GPVI-dimers for all three collagenous substrates and are not associated 
with the Horm fibres. Integrin α2β1 bound to the Horm collagen fibres, following a similar 
pattern as the GPVI-dimer clusters, coinciding with GPVI-dimer clusters at some points, but 
not associated with the lammelipodia of the platelets spread on Col III or III-30. C: TIRF 
images (15-min time point, upper row in each 4-image group) and DIC images (lower row in 
each 4-image group). Platelets were prelabelled with Alexa-fluor 488–204-11 Fab, treated 
with Gi9 (anti-integrin α2β1, 5 μg/ml; + Gi9) or an equal volume of PBS (No Gi9), and 
allowed to adhere on Col III or Horm under TIRF monitoring for 30 min. Gi9 treatment 
decreased but did not prevent adhesion and GPVI-dimer clustering on fibrous Horm 
collagen, but little or no adhesion was seen on collagen type III even at the 30-min time 
point. 
Fig. 5. Phospho-tyrosine staining and GPVI-dimer clustering. 
To determine if signalling reactions may be occurring in the vicinity of GPI-dimer clusters, 
washed platelets were prelabelled with Alexa-fluor 488–204-11 Fab and allowed to adhere 
on collagenous substrate, followed by formalin fixation, permeabilization with 0.5% 
Triton/PBS, and staining with 4G10 (anti-phosphotyrosine)/Alexa-fluor-647 conjugated anti-
mouse Fc. The experiments shown are performed with platelets of one donor, on the same 
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day, and same imaging conditions.  A: Confocal images show that visually, phospho-tyrosine 
(P-tyr, red) was found among but not necessarily coincident, with the GPVI-dimer clusters 
(green) for platelets adhered to Col III, CRP-XL, and  III-30. Notably, the P-tyr staining in 
platelets adhered to Horm collagen very closely followed the pattern of GPVI-dimer staining, 
which was mainly confined to the fibres.  The morphology of spread platelets was identified 
by transmitted light.   
B: Calculation of colocalization. In the left-side set of figures, colocalised pixels are 
presented as a binary threshold mask, calculated by Image Pro Premier ver. 9.2 (Media 
Cybernetics); they correspond to the respective merged images in 5A.  The right-side graph 
shows the calculated Pearson’s correlation coefficients for co-localization (mean ±SD), 
calculated from 9–11 images, and are as follows: Horm collagen (0.176 ± 0.016); collagen 
type III (0.106 ± 0.046), CRP-XL (0.216 ± 0.024), and toolkit peptide III-30 (0.079 ± 0.057); 
the Pearson coefficients of the representative images shown in Fig. 5A are 0.178, 0.166, 
0.179, 0.074, for Horm collagen, Col III, CRP-XL, and III-30, respectively.   The Pearson’s 
coefficient for Horm collagen is significantly different from that of Col III (***P0.001) and III-
30 (***P0.001), but not different from that of CRP (paired t-test, Prism v7).These values 
suggest that only some GPVI-dimer clusters are localized with regions of high signalling 
activity; it is notable that under the limitations of the resolution afforded by the confocal 
microscope, both GPVI-dimer clustering and signalling can be seen along the Horm collagen 
fibers. 
Fig. 6.  Effect of signalling inhibitors on GPVI-dimer cluster formation in live platelets 
adhering to immobilized collagenous substrate.   
Alexafluor-488–204-11 labelled platelets were reacted with DMSO (vehicle), 10 μM PP2, or 
PRT (5 μM) and then their adhesion to immobilized collagenous substrate was followed by 
TIRF. PRT markedly inhibited platelet adhesion to all substrates, but the platelets that did 
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adhere still showed GPVI-dimer cluster formation.  The effect of PP2 was weaker but similar 
to that of PRT. 
Fig. 7. Effect of actin antagonists on GPVI dimerization and GPVI-dimer clustering. 
A: Raw flow-cytometry data: Effect of the actin antagonists latrunculin A (Lat A) and 
jasplakinolide (Jas) on the level of dimers in resting and activated washed platelets were 
determined by flow cytometry (Accuri C6) using FITC-labeled mFab-F (dimer-specific). Panel 
A provides a representative histogram and dot-plots of the control (Control, FITC-anti-human 
Fab), non-treated resting platelets (No inhibitor, vehicle DMSO at 0.2% final concentration), 
and Lat A (10 μM)–treated resting platelets (+ Lat A). There are no obvious differences in the 
platelet region (SSC-A vs. FL1-A plot) in the Lat-A–treated and non-treated resting platelets. 
However, the histogram (upper graph in panel A, FLA-1 vs. count) shows that Lat A 
treatment markedly decreases the level of GPVI-dimers, as evidenced by the clear leftward 
shift of the Lat A–treated platelets relative to the untreated resting platelets.  B: Comparison 
of effects of actin-antagonists on GPVI-dimer level in resting and activated platelets. Washed 
platelets were treated with the vehicle DMSO or an actin antagonist at 10 μM: cytochalasin 
D (cyt), lartrunculin A (lat), or jasplakinolide (jas) and then added with Hepes Tyrodes buffer 
(resting), CRP, or thrombin. The samples were processed for flow cytometry using FITC–
mFab-F or FITC-anti-human Fab (control). Differences among treatment groups were 
calculated by paired t-test, by PRISM ver. 7. All tested actin inhibitors decreased GPVI-
dimers (MFI, mean ±SEM) in resting platelets [cyt, lat, jas, each P0.05, n = 5, compared to 
the vehicle alone (0.2% DMSO, final concentration, n = 8)]; CRP-XL–induced platelets [cyt, 
lat, jas, each P 0.05 (n = 5), compared to 0.2% DMSO]; and thrombin-induced platelets [cyt 
and jas, each P0.05 (n = 5), and lat, P<0.005 (n = 5), compared to 0.2% DMSO).  C – F: 
Confocal images of GPVI-dimers and F-actin in non-treated and actin-antagonist–treated 
platelets adhered to Horm (C), Col III (D), CRP-XL (E), and III-30 (F). Washed platelets 
labeled with Alexa-fluor 488–204-11 Fab (green), with or without treatment with Lat A or Jas,  
were allowed to adhere on immobilized collagenous substrate, formalin-fixed, permeabilized, 
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and then stained for F-actin with Alexa-fluor 647–phalloidin. Lat A (2 μM) and Jas (2 μM) 
were used at threshold inhibitory concentrations, so that platelet adhesion is not completely 
prevented. Images were obtained on a confocal microscope; the following images are 
shown: grey scale images of the GPVI-dimer and F-actin; merged images (green = GPVI-
dimer clusters and red = F-actin), and transmitted light images.  Lat A severely inhibited the 
formation of large GPVI-clusters, but a limited number of small clusters could still be 
observed for platelet adhesion to all tested collagenous substrates.  The spreading is clearly 
inhibited on all the collagenous substrates. Jas produced more severe inhibition of F-actin 
and no F-actin staining could be observed in the Jas-treated platelets. In the Jas-treated 
platelets, some green fluorescence could still be observed in the adhered cells, but it is not 
clear whether this corresponds to small GPVI-clusters or is due to the higher density of 
residual GPVI-dimers due to the much more compact size of the non-spread platelets. Note 
that in spite of the cytoskeleton being severely compromised in the inhibitor-treated platelets 
and the total inhibition of spreading, there is residual ability for the platelets to adhere to the 
collagenous substrates, possibly due to GPVI-dimers, and this is most evident in the 
platelets adhered along the Horm collagen fibers in the Lat A–  or Jas- treated preparations. 
 
Table I. Collagenous substrates used in this study 
Collagenous substrate Abbr Description Structure Collagen receptor 
specificity 
aCollagen-related peptide-XL  
 
CRP-XL Triple helical, 
crosslinked 
*GCO-(GPO)10GCOG-NH2 GPVI 
bCollagen Toolkit III peptide 30 III-30 Triple helical *GPC-(GPP)5-GAOGARGGA- 
GPOGPEGGKGAAGPOGPO- 
(GPP)5-GPC-NH2 
GPVI 
cHorm collagen (equine, type I) Horm Fibrous 
Type I 
[α1(I)]2α2(I) GPVI 
Integrin α2β1 
dBovine collagen type I Col I Non-fibrous [α1(I)]2α2(I) GPVI 
Integrin α2β1 
dBovine collagen type III Col III Non-fibrous [α1(III)]3 GPVI 
Integrin α2β1 
  
*GPVI-binding GPO triplets are shown in bold print for CRP and III-30 
a Cross-linked Collagen Related Peptide (CRP-XL) was synthesized as described by Morton et al. [29].  
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b  Triple-helical peptide III-30 is from the Collagen Toolkit III, a set of overlapping triple helical 
peptides encompassing the entire Col domain of human collagen III; it was synthesized as described 
by Raynal et al. [30].  
c Nycomed Pharma GmbH (1 mg/ml; Munich, Germany).   
d Koken Co., Ltd. (3 mg/ml; Tokyo, Japan) 
 
 
Supplementary Movie 
GPVI forms clusters when platelets spread on immobilized collagenous substrates.  TIRF 
microscopy time course of washed human platelets, labelled with Alexa 488 labelled dimer-
specific 204-11 Fab, interacting with 10µg/ml immobilized collagenous substrates at 37oC. (A 
(i)) Horm collagen, (B) CRP-XL, (C) peptide III-30 and (D) non-fibrous collagen  III.  Movies 
are a single platelet representative of three independent experiments.  Frames were taken 
every 5 seconds. Time stamp: seconds. Scale bar: 2 µm. 
Supplemental Fig. 1. DIC images corresponding to the fluorescence images in Figure 6.  
Platelets were reacted with DMSO (vehicle), 10 μM PP2, or PRT (5 μM) and then their 
adhesion to immobilized collagenous substrates was followed by DIC. PRT markedly 
inhibited platelet adhesion to all substrates, but the platelets that did adhere still showed 
GPVI-dimer cluster formation.  The effect of PP2 was weaker but similar to that of PRT. 
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